Whether you are interviewing for a PGY1, PGY2, or clinical specialist position, you will want to listen to this jam-packed episode of advice from panelists who have experience conduction interviews for all of these positions! Transplant clinical specialists, Drs. Nick Parrish and Rickey Evans, join hosts Lauren, Kim, and Stephanie to discuss anything and everything you have wanted to know about pulling off a successful interview. From prep, to wardrobe, to modern-day follow-up etiquette, we've got you covered!

In this episode of The mTOR You Know, we dive into the evolving role of pharmacogenomics in solid organ transplantation with a focus on tacrolimus andCYP3A5. Our expert panel—Jennifer Trofe, Amy Pasternak, and Shirley Tsunoda—share insights on clinical trial data, guideline perspectives, and real-world application of genotype-guided dosing. We explore the benefits and limitations of CYP3A5 testing, touch on other transplant medications with pharmacogenomic considerations, and discuss barriers such as cost, access, and implementation. The conversation also highlights national survey findings,cost-effectiveness analyses, and strategies for integrating pharmacogenomics into clinical practice.

Literature/Resources mentioned:

• ASERTAA Trial
• Assessing the Utility of a Genotype-Guided Tacrolimus Equation in African American Kidney Transplant Recipients
• Publications discussing benefits of CYP3A5 testing: 1. Anutrakulchai et al, 2. Lloberas et al, 3. Thervet et al
• CPIC® Guideline for Tacrolimus and CYP3A5
• Survey of the utilization of genotype-guided tacrolimus management in United States solid organ transplant centers
• National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation
• Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation
• Cost-benefit analyses of CYP3A5 testing for tacrolimus in transplant recipients: 1. Deininger et al, 2. Pasternak et al, 3. Wang et al,
• Decoding Pharmacogenomic Test Interpretation and Application to Patient Care

In case you missed the live event or would like to revisit the discussion, we are bringing you another opportunity to tune in here! Join moderators Dr. Emily Sartain and Dr. Barrett Crowther as they chat with panelists Dr. Dawn Pluckrose, Dr. Idris Yakubu, Dr. Kayla Joyal, and Dr. Lyndsey Bowman Anger on Mentorship Tips and Tricks. Thank you to the ACCP Txp PRN Programming Committee and the AST Pharmacy COP for bringing us this webinar. All webinars can also be found on the ACCP Transplant PRN YouTube channel.

We’re back with Part 2 of our CMV series! Hosts Aileen Chi and Xena Huang return with the expert panel from the University of Wisconsin—Margaret Jorgenson, Jillian Fose, and Hanna Kleiboeker—to continue the conversation on CMV management in cardiothoracic transplant. In this episode, we explore tricky real-world cases, discuss strategies for managing antiviral resistance, and learn how this team built their renowned CMV stewardship program.

In this episode, we’re bringing you the audio from a recent ACCP joint webinar hosted by the Cardiology and Transplant PRNs—featuring pharmacist-curated highlights from the 2025 ISHLT meeting!

Join Dr. Ian Hollis (UNC Health), Dr. YeeAnn Chen (University of Rochester Medical Center), and Dr. Xena Huang (NewYork-Presbyterian/Columbia) as they break down key takeaways in mechanical circulatory support, heart transplantation, and lung transplantation.

Missed the live session? No worries—we’ve got you covered.

Staying ahead of CMV is crucial for cardiothoracic transplant patients. In this episode, the first of a two-part series, hosts Aileen Chi and Xena Huang welcome a panel of experts from the University of Wisconsin: Dr. Margaret Jorgenson, Dr. Jillian Fose, and Dr. Hanna Kleiboeker. Join us as we delve into the complexities of CMV monitoring and management in this high-risk patient population. Our guests will share their insights on current best practices, diagnostic strategies, antiviral therapies, and the latest research aimed at improving patient outcomes and reducing CMV-related complications.

Join PGY2 SOT Pharmacy Resident Melissa Vu Maffei to discuss “The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes.”

PGY2 SOT Brittany Huynh joins us from the University of California, San Diego Health to discuss “Evaluation of lipid management practices for secondary atherosclerotic cardiovascular disease prevention in abdominal solid organ transplant recipients”

PGY2 SOT Kylea Clark joins us from the University of Alabama at Birmingham to discuss “Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients.”

Transplant surgeons Dr. Manish Gupta and Dr. Garrett Roll chat with hosts Aileen Chi and Kimberly Leale on this exciting multidisciplinary episode of The mTOR You Know. Join us as we learn amazing insight about new surgical technology and its impacts on immunosuppression, outcomes, and the global transplant ecosystem. You're going to want popcorn for this one!